|Legal and Administrative
Details|Legal and Administrative
Details||||
|---|---|---|---|---|
|Chairman's|Annual
Report|||3-4|
|Trustees'
Report,
including
the Strategic report||||5-21|
|Independent|Auditor's
Report|||22 - 25|
|Consolidated|Statement
of Financial Activities|||26|
|Comparative|Consolidated
Statement|of Financial|Activities|27|
|Consolidated|Balance Sheet|||28|
|Charity
Balance Sheet||||29|
|Consolidated|Statement
of Cash Flows|||30|
|Princi pa I accounting
policies||||31-34|
|Notes to the|financial
statements|||35 - 53|
##
##
##
|
the Truste|
the Truste|
es.|||||||
|---|---|---|---|---|---|---|---|---|
|Company||registration|number:|01231909|||||
|Charity|registration||number;|270194|||||
|Registered||Office:||Milton Road|||||
|||||Willen Village|||||
|||||Milton Keynes|||||
|||||MK15 9AB|||||
|Trustees:||||P Davis (Chairman) ' ''
I Philpott ''
M Stevenson '' "
R Gilbert ' 4'
G Ball '' "(Resigned
December 2020)|||||
|||||C Dunn'
M Rogers'''
S Carbert '|||||
|||||3 Wood
2
A Coombes '
C White-Robinson
M Esam '|'||||
|||||Member of|Business||Development||
|||||Committee/WHV
Ltd|||Board||
|||||Member of|General|Purposes
&||Finance|
|||||Committee|(Including||IM&T)||
|||||Member of|People|Services Committee|||
|||||Member of|Property||Committee||
|||||Member of|Clinical|Governance||Committee|
|||||Member of|Health|&|Safety Committee||
|||||Integrated
Governance
Committee|||||
##
##
|Legal a|nd Adminis|trative
Detail|s|(|continued)||
|---|---|---|---|---|---|---|
|Bankers:||Barelays|||||
|||4 The Waterside||Way|||
|||Bedford Road|||||
|||Northampton|||||
|||NN4 7XD|||||
|||NatWest|||||
|||501 Silbury
Boulevard|||||
|||Saxon Gate East|||||
|||Milton Keynes|||||
|||MK9 3ER|||||
|||Metro Bank|||||
|||One Southampton|||Row||
|||London|||||
|||WC1B 5HA|||||
|||Handelsbanken|||||
|||2nd Floor Clifton||House|||
|||4A Goldington|Road||||
|||Bedford|||||
|||MK40 3NF|||||
|Solicitors:||Geoffrey Leaver Solicitors|||||
|||251 Upper Third||Street|||
|||Bouverie Square|||||
|||Milton Keynes|||||
|||MK9 1DR|||||
|Independent|Auditor:|Mercer S.Hole
Chartered
Accountants 5 Registered||||Auditor|
|||420 Silbury
Boulevard|||||
|||Milton Keynes|||||
|||MK9 2AF|||||
|Investment|Advisors:|Rathbones|||||
|||8 Finsbury
Circus|||||
|||London|||||
|||EC2M 7AZ|||||
|||Sarasin h Partners|||LLP||
|||3uxon House|||||
|||100St Paul's|Churchyard||||
|||London|||||
|||EC4M SBU|||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|As at 31 March 2021:|||
|---|---|---|
|Designated
reserves||5,784,320|
|Unrestricted
general
reserves||7,196,482|
|Total free reserves||12,980,802|
|Less fixed asset designated|reserves:||
|Property||(1,863,079)|
|Hospice development||(3,378,232)|
|Other fixed assets||(444,009)|
|||7,295,482|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||Funds|Funds|2021|2020|
|||||||Note|||f|f|
|Income|||||||||||
|Donations
and|voluntary||Income||||||||
|Voluntary
income||||||1|3,118,933|926,592|4,045,525|3,645,255|
|Grant funding||||||||1,636,834|1,636,834||
|Income from generated|||funds||||||||
|Income from|Clinical||Commissioning||Group||1,294,877||1,294,877|1,332,283|
|Activities
for|raising|funds|||||1,156,552||1,156,552|1,516,231|
|Investment
income|||||||225,649||225,649|246,018|
|Other Income|||||||1,569,378||1,569,378|345,787|
|Total income|||||||7 365389|2563 426|9 928 815|7 085574|
|Expenditure|||||||||||
|Cost of raising|funds|||||7|(2,223,916)||(2 223 916)|(2 345 901)|
|Charitable
activities
Impairment
of Investments||||||7
13|(3,109,546)
198438|(1,959,866)|(5,069,412)
198436|(4,454,606)
~197 021|
|Total expenditure|||||||||||
|Gain / (Loss) on investment||||assets||13|1 058 692||1 058 692|~307 260|
|Net income /|(expenditure)||||||3,289,057|603,560|378927617|(2197214)|
|Transfers|||||||||||
|Net movements
in funds|||||||3,289,057|603,560|3,892,617|(219,214)|
|Fund balances
brought||forward at|||||||||
|1 April 2020|||||||10924 241|47 036|10971 277|11 190491|
|Fund balances
March 2021|carried||forward at||31|20/22|14213298|650 596|14863 894|10971277|
##
|Activities
(in
accGUnt)|c|or|pol.|ating an i|ncome and ex|penditome||
|---|---|---|---|---|---|---|---|
||||||Unrestricted||Total|
||||||Funds|Funds|2020|
||||||E|E|E|
|Income||||||||
|Donations
and voluntary||income||||||
|Voluntary
income|||||3,603,572|41,683|3,645,255|
|Income from generated|funds|||||||
|Income from Clinical|Commissioning|||Group|1,332,283||1,332,283|
|Activities
for raising|funds||||1,516,231||1,516,231|
|Investment
income|||||246,018||246,018|
|Other income|||||345,787||345,787|
|Totallncome|||||7,043,891|41,683|7,085,574|
|Expenditure||||||||
|Cost of raising
funds|||||(2,345,901)||(2,345,901)|
|Charitable
activities
Impairment
of investment|||||(4,404,296)
197021|(50 310)|(4,454,606)
~19?021|
|Total expenditure|||||(6,947,218)|(507310)|(679977528)|
|(Loss) / Gain on investment|||assets||307 260||307 260|
|Net income / (expenditure)|||||(210,587)|(8,627)|(219,214)|
|Transfers||||||||
|Net movements
in funds|||||(210,587)|(8,627)|(219,214)|
|Fund balances
brought|forward at 1 April|||||||
|2019|||||11134828|55 663|11 190491|
|Fund balances carried
2020||forward at||31 March|10924 241|47036|10971277|
##
||||Note|2021
E|2021f|2020|2020
E|
|---|---|---|---|---|---|---|---|
|Fixed assets||||||||
|Intangible
assets|||||32,687||21,788|
|Tangible assets|||12||2,583,414||2,505,917|
|Investments|||13||8 190880||6 793 714|
||||||10,806,981||9,321,419|
|Current assets||||||||
|Stocks|||14|35,531||57,613||
|Debtors|||15|2,013,665||1,159,016||
|Cash and cash equivalents|||16|2 824 684||938 621||
|||||4,623,880||2,155,250||
|Creditors: amounts
one year||falling due within|17|(566,967)||505 392||
|Net current assets|||||4,056,913||1,649/858|
|Net assets|||||14,863,894||10,971,277|
|Income
Funds||||||||
|Restricted
funds|||20||650,596||47,036|
|Unrestricted
f'unds||||||||
|Designated
funds|||21||5,784,320||6,223,615|
|Other charitable|funds||22||7,196,482||4,526,822|
|Revaluation
reserve|||22||1 232 496||173804|
|Total funds|||||14,863,894||10,971,277|
##
|||||Note|2021f|2021|2020
E|2020
E|
|---|---|---|---|---|---|---|---|---|
|Fixed assets|||||||||
|Intangible
assets||||||32,687||21,788|
|Tangible assets||||12||2,583,414||2,505,917|
|Investment
In subsidiary|||undertaking|13||2||2|
|Investments||||13||8 190880||6 793714|
|||||||10,806,983||9,321,421|
|Current assets|||||||||
|Debtors||||15|2,368,260||1,066,248||
|Cash and cash equivalents||||16|1 854 049||648 910||
||||||4,222,309||1,715,158||
|Creditors: amounts
one year||falling due within||17|~311584||295 871||
|Net current assets||||||3,910,725||1,419,287|
|Net assets||||||14717 708||10740 708|
|Income Funds|||||||||
|Restricted
funds||||||650,596||47,036|
|unrestricted
funds:|||||||||
|Designated
funds||||21||5,784/320||6,223,615|
|Other charitable|funds|||22||7,050,296||4,296,253|
|Revaluation
reserve||||22||1 232 496||173804|
|Totaifunds||||||14 717 708||10740 708|
##
|||||2021|2021|2020|2020|
|---|---|---|---|---|---|---|---|
||||Notes|||||
|Cash flows from operating||activities||||||
|Net income / (expenditure)||||3,892,617||(219,214)||
|Adjustments
for:||||||||
|Investment
income||||(225,649)||(246,018)||
|Amortisa tion|||11|7,792||6,467||
|Depreciation|||12|189,740||140,962||
|(Increase)/decrease
in stocks|||14|22,082||(2,718)||
|(Increase)/decrease
in trade||and|15|(854,649)||(463,371)||
|other receivables||||||||
|(Decrease)/Increase
in trade||and other|17|61,575||(29,482)||
|paya bles||||||||
|Movement
on pension
scheme|||17|||(386,064)||
|Revaluation
of investments
Impairment
of investments|||13
13|(1,059,667)
(198,438)||307,260
197,021||
|Cash flows generated
from|||||1,835,403||{695,157)|
|operating
activities||||||||
|Purchase of property
plant and|||12|(267,237)||(326,313)||
|equipment||||||||
|Purchase of intangible
fixed assets
Purchase of investments
Proceeds from sale of investments|||11
13
13|(18,691)
(145,147)
6,086||(20,669)
(943,461)
201,705||
|Investment
income||||225 649||246 018||
|Cash flows generated
from||investing|||(199,340)||(842,720)|
|activities||||||||
|Net (decrease) / increase|in cash||||1,636,063||(1~537~877)|
|and cash equivalents||||||||
|Cash and cash equivalents
at|1 April||||938,621||2,476,498|
|Cash and cash equivalents
at|31 March||16||2 574684||938621|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Donations|and v|oluntar|y
in|come||||
|---|---|---|---|---|---|---|---|
|||||||Total|Total|
||||Unrestricted||Restricted|2021|2020|
|||||||E|E|
|Donations
(Including||gift aid)|1,186,162||926,592|2,112,754|1,122I028|
|Gifts in kind||||47,447||47,447|31,768|
|Legacies||||962,435||962,435|840,034|
|Memorials||||244,692||244,692|258,658|
|Donated
goods||||650,678||650,678|1,342,767|
|Friends of Willen|||||||50,000|
|Christmas
Appeal||||27,519||27,519||
|Grant
funding|||||1,636,834|1,636,834||
||||3|118933|2 563 426|5 682 359|3 645 255|
|Activities for raising funds||||||||
|||||||2021|2020|
||||||||E|
|Unrestricted|funds|||||||
|Lottery income||||||466I231|509,026|
|Events and promotlons||income||||610,659|826,929|
|Income from Willen Hospice Ventures||||shops||79 662|399644|
|||||||1,156,552|1,735,599|
|Xnvestrnent|income|||||||
|||||||2021|2020|
|||||||E|f|
|Unrestricted|funds|||||||
|Listed investments||||||224,981|242,379|
|Bank deposits||||||668|3 639|
|||||||225,649|246,018|
##
##
##
|||||2021|2020|
|---|---|---|---|---|---|
|||||f.|F.|
|Unrestricted|funds|||||
|Education||||35,799|72,829|
|Catering||||16,442|30,277|
|Job Retention|Scheme|||229,326|5,490|
|CCG COVID-19 Funding||||875,373||
|Business Interruption|||Scheme Claim|194,069||
|Retail business|support||grant|191,835|215,000|
|Other miscellaneous||Income||9,867|22,191|
|Shop Rent||||16 667||
|||||1,569,378|345,787|
##
|ompany
num|be|r:
2479448) is|set out below:||||
|---|---|---|---|---|---|---|
||||||2021|2020|
||||||6|E|
|Turnover|||||1,635,272|2,477,156|
|Cost of sales|||||169834|332 994|
|Gross profit|||||1,465,438|2,144,162|
|Administrative
expenses|||||(1,767,598)|(1,827,703)|
|Other operating|income||||556,851|219,368|
|Operating
profit|||||254,691|535,827|
|Interest receivable||and similar income|||184|325|
|Profit for the year and total comprehensive
income|||||254,875|536,152|
|The net assets||and liabilities of the subsidiary||were:|||
||||||2021|2020|
|Current
assets|||||1,068,621|702,966|
|Creditors:
amounts||falling due within|one year||(922,433)|(472,395)|
|Creditors:
amounts||falling due after one year|||||
|Total net assets|||||146,188|230,571|
|Aggregate
share|capital and reserves||||146,188|230,571|
##
##
##
##
|nalysis|of|expen|diture|||||
|---|---|---|---|---|---|---|---|
||||||Support|||
|||||Direct costs|costs|Total|Total|
||||||(Note below)|2021|2020|
||||||f||E|
|Cost of raising funds||||||||
|Trading||||1,250,957|44,739|1,295,696|1,417,100|
|Lottery||||191,496|19,724|211,220|225,012|
|Events and fundraislng||||304,688|111,673|416,361|448,568|
|Voluntary|fundraising||costs|300639||300639|255 221|
|||||2,047,780|176,136|2,223,916|2,345,901|
|Charitable|activities|||||||
|In house||||2,606,921|238,277|2,845,198|2,603,772|
|Willen
At Home||||1,035,947|84,009|1,119,956|1,032,358|
|Wellbeing|86 Therapeutic|||701,178|71,055|772,233|497,342|
|Lymphoedema||Service||200,323|30,900|231,223|224,103|
|Governance||||12610|88 192|100 802|97 031|
|||||4,556,979|512,433|5,069,412|4,454,606|
|Other expenses||||||||
|Impairment|of|investments||||||
|Total expenditure||||6,604,7S9|490,131|7,094,890|6,997,528|
##
##
##
|Total exp|end|iture
includes:|||||
|---|---|---|---|---|---|---|
|||||The group|The charity||
||||2021|2020|2021|2020|
||||f|||E|
|Auditor
remuneration|||||||
|Audit services|||12,150|10,300|||
|Non-audit|services||1,350|2,145|||
|Amortisatlon|||7,792|6,467|7,792|6I467|
|Depreciation|||189,740|140,962|189,740|140,962|
|Other operating||lease rentals|(6,728)|35,352|(6,728)|35,352|
##
|||2021|2020|
|---|---|---|---|
|Salaries and wages||4,318,025|4,017,677|
|Social security costs||379,961|344,378|
|Pension costs||391,514|351,000|
|||5,089,500|4,713,055|
|Contract staff||367,029|264,383|
|Health
Examination|fees|329|635|
|||5,456,858|4,978,073|
##
##
##
##
##
|te|s to the|financial statement|s
(continued)||
|---|---|---|---|---|
|11|Intangible|fixed assets|||
||The group and the charity||||
||||ITsoftware|Total|
||||E||
||Cost||||
||At 1 April 2020||97,014|97,014|
||Additions||18,691|18,691|
||Disposals||||
||At 31March|2021|115,705|115,705|
||Amortisation||||
||At 1 April 2020||75,226|75,226|
||Amortisation|in the year|7,792|7,792|
||On disposals||||
||At 31March|2021|83,018|83,018|
||Net book amount at 31March 2021||32,687|321687|
||Net book amount at 31March 2020||21,788|21,788|
##
##
||||Asset under|||
|---|---|---|---|---|---|
|||Freehold|course of||Fundraising|
|||property|construction|Equipment|assets|
|||||E||
|Cost||||||
|At 1 April 2020||3,053,004|288,524|616,155|372,212|
|Additions|||20,502|30,064|17,264|
|Disposals|||||11080|
|At 31March|2021|3,053,004|309,026|646,219|378,396|
|Depreciation||||||
|At 1 April 2020||1,129,708||504,199|299,030|
|Depreciation|in the year|60,223||21,963|18,385|
|Disposals|||||(11,080)|
|At 31March|2021|1,189,931||526,162|306,335|
|Net book amount at||||||
|31March 2021||1,863,073|309,026|120,057|72,061|
|Net book amount at||||||
|31March 2020||1,923,296|288,524|111,956|73,182|
##
##
|||IT|Motor|Leasehold||
|---|---|---|---|---|---|
|||hardware
f|vehicles|improvements
E|Total|
|Cost||||||
|At 1 April 2020||235,122|42,774|4,798|4,612,589|
|Additions||46,178||153,229|267,237|
|Disposals|||||11080|
|At 31March|2021|281,300|42,774|158,027|4,868,746|
|Depreciation||||||
|At 1 April 2020||143,776|29,430|529|2,106,672|
|Depreciation|in the year|46,182|7,060|35,927|189,740|
|Disposals|||||(11,080)|
|At 31March|2021|189,958|36,490|36,456|2,285,332|
|Net book amount at 31||||||
|March 2021||91,342|6,284|121,571|2,583,414|
|Net book amount at 31||||||
|March 2020||91,346|13,344|4,269|2,505,917|
##
##
##
||||Historical||||Market|
|---|---|---|---|---|---|---|---|
||||cost|Impairment||Revaluation|value|
||||E||E|E|E|
|Valuation||||||||
|At 1 April 2020|||6,818,348|(198,438)||173,804|6,793,714|
|Purchases
and|additions|from|145,147||||14S,147|
|reinvestment||||||||
|Dlsposals|||(5,111)|||(975)|(6,086)|
|(Impairment)|/ reversal|of||198,438|||198,438|
|impairment||||||||
|Realised
Gain||||||||
|Unrealised
gain on revaluation||||||1,059,667|1I059I667|
|At 31March|2021||6,958,384|||1,232,496|8,190,880|
##
||||2021|2020|
|---|---|---|---|---|
||||E|E|
|Goods|for|resale|35531|576i3|
##
##
##
||||||||The group|The group|||The charity|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||2021|||2020|2021|2020||
|||||||||||E||E||
||Trade|debtors|||||50,711|||22,788|48,156|16,865||
||Other|debtors|||||128,316|||69,945|116,178|46,756||
||Prepayments||and|accrued||||||||||
||income||||||1,834,638||1,066,283||1,536,876|739,753||
||Amounts
owed by subsidiary|||||||||||||
||undertaking||||||||||667 050|262 674||
||||||||2,013,665|1,159,016|||2,368,260|1,066,248||
|16|Cash and cash||||equivalents|||||||||
||||||||The group||||The charity|||
||||||||2021|||2020|2021|2020||
|||||||||||E|||E|
||Cash at|bank and||in|hand||2,538,046|||900,179|1,817,411|610,468||
||Cash held at investment|||||manager|36,638|||38,442|36,638|38,442||
||||||||2,574,684|||938,621|1,854,049|648,910||
|17|Creditors: amounts|||||falling|due vvithin|one||year||||
|||||||||The|group||The charity|||
||||||||2021|||2020|2021|2020||
||Trade creditors||||||87,321|||137,196|75,096|107,570||
||Social security||and|other||taxes|91,913|||84,537|78,094|70,568||
||Pension|contributions|||||59,542|||52,243|53,654|47,088||
||Other creditors||||||1,245|||6,207|17062|6,008||
||Accruals|and deferred|||Income||326 946|||225 209|103678|64|637|
||||||||566,967|||505,392|311584|295|871|
##
##
|18|Financial
instruments|Financial
instruments|||||||
|---|---|---|---|---|---|---|---|---|
||||||The group||The charity||
||||||2021|2020|2021|2020|
|||||||E||E|
||Financial|assets:|||||||
||Financial|assets measured|at|fair|||||
||value through
profit and loss||||2,574,684|938,621|1,854,049|648,910|
||Financial|assets measured|at||||||
||amortised|cost|||1,811,040|982,602|2,249,265|1,001,364|
||||||4,385,724|1,921,223|4,103,314|1,650,274|
||Financial|liabilities:|||||||
||Financial|liabilities
measured||at|||||
||amortised|cost|||336,994|106,985|224,418|100,553|
##
|Group|—current year||||
|---|---|---|---|---|
|||Unrestricted
fundsf|Restricted
fundsf|Total funds|
|Intangible
fixed assets||32,687||32,687|
|Tangible|fixed assets|2,583,414||2,583,414|
|Investments||8,190,880||8,190,880|
|Current|assets|3,973,284|650,596|4,623,880|
|Current|liabilities|(566,967)||(566,967)|
|||14213298|650,,596|14,863,894|
##
##
|Analysis
of net asse|ts be|tween|funds (co|ntinued)||
|---|---|---|---|---|---|
|Group —comparative|year|||||
||||Unrestricted
fundsf
Restricted
funds
E||Total fundsf|
|Intangible
fixed assets||||21,788|21,788|
|Tangible
fixed assets|||2,505,917||2,505,917|
|Investments|||6,793,714||6,793,714|
|Current assets|||2,108,214
47,036||2,155,250|
|Current
liabilities||||(505,392)|(505,392)|
||||10,924,241
47 036||10,971,277|
|Restricted
funds||||||
|The group and the charity||—current year||||
||||||At|
||At 1|April
2020|Income|Expenditure
Transfers|31March
2021|
||||||E|
|Education|3,287|||(1,005)|2,282|
|Clinical equipment|5,364||13,566|(12,166)|6,764|
|Willen at Home|||33,043|(32,786)|257|
|Capital Appeal|7,790||302,055||309,845|
|Wellbelng
and Therapeutic|3,382||66,160|(46,324)|23,218|
|Miscellaneous|27,213||47,565|(45,189)|29,588|
|CCG COVID-19 Funding|||286,988|(8,347)|278,641|
|Hospice
UK Funding|||] 636834|(1,636,834)||
|Cancer Care in the|||140,841|( 140,841)||
|Community||||||
|Bereavement
Project|||36,375|||
|Total|47,936||2,563,427|(2,959,667)|6507S96|
##
##
##
##
##
##
||||||||At|
|---|---|---|---|---|---|---|---|
||||At 1 April
2019
E|Income
6|Expenditure
E|Transfers
f|31March
2020
E|
|Education|||4,327||(1,040)||3,287|
|Clinical|equipment||12,674||(7,310)||5,364|
|Willen|at|Home||9,250|(9,250)|||
|Capital|Appeal|||7,790|||7,790|
|Wellbeing||and Therapeutic||16,700|(13,318)||3,382|
|Miscellaneous|||38,662|7,943|(19,392)||27,213|
|Total|||55,663|41,683|(50,310)||47,036|
##
##
##
|The group and the charity
—|current year||||
|---|---|---|---|---|
||||Transfers||
||At 1April
2020|Expenditure|(see
below)|At 31 March
2021|
|||E|E||
|Property|1,982,975|(60,223)|(59,673)|1,863,079|
|Hospice development|3,788,061|(20,502)|(389,328)|3,378,232|
|Other fixed assets|261,779|(137,309)|319,539|444,009|
|The Well|83,000|(83,000)|||
|Retail outlet refurbishment|18,000|(7,040)|(5,960)|5,000|
|IT replacement|59,000|(59,000)|25,000|25,000|
|Clinical equipment|||36,000|36,000|
|Planned
preventative|||||
|maintenance|30,800||2,200|33,000|
|Total|6,223,615|(367,073)|(72,222)|5,784,320|
##
##
|The group and the charity
—|comparative
year||||
|---|---|---|---|---|
||||Transfers||
||At 1April
2019|Expenditure|(see
below)f|At 31March
2020|
|Property|1,986,220|(62,921)|59,676|1,982,975|
|Hospice development|4,000,000|(211,939)||3,788,061|
|Other fixed assets|265,347|(84,653)|81,085|261,779|
|The Well|||83,000|83,000|
|Retail outlet refurbishment|28,000|(6,777)|(3,223)|18,000|
|IT replacement|142,314|(124,091)|40,777|59,000|
|Clinical equipment|17,941|(3,300)|(14,641)||
|Planned
preventative|||||
|maintenance|47,799||(16,999)|30,800|
|Total|6,487,621|(493,681)|229,675|6,223,615|
||Designated|Other|||
|---|---|---|---|---|
||funds (see
note 21)|charitable
funds|Revaluation
reserve|Total|
||||E|E|
|At 1 April 2020|6,223,615|4,526,822|173,804|10,924,241|
|Income||7,365,389||7,365,389|
|Expenditure|(367,073)|(4,767,951)||(5,135,024)|
|Gain / (loss) on revaluation|||1,058,692|1,058,692|
|Transfers (see note 13521)|||||
|At 31March 2021|5,784,320|7,196,482|1,232,496|14,213,298|
##
##
||Designated|Other|||
|---|---|---|---|---|
||funds (see
note 21)|charitable
funds
E|Revaluation
reservef|Total|
|At 1 April 2019|6,487,621|4,127,368|519,839|11,134,828|
|Income||7,043,891||7,043,891|
|Expenditure|(493,681)|(6,453,537)||(6,947,218)|
|Gain / (loss) on revaluation|||(307,260)|(307,260)|
|Transfers (see note 13521)|229 675|190900|38 775||
|At 31March 2020|6,223,615|4,526,822|173,804|10,924,241|
||Designated
funds (see
note 21)|Other
charitable
funds
E|Revaluation
reserve
f|Total
E|
|---|---|---|---|---|
|At 1 April 2020|6,223,615|4,296,253|173,804|10,693,672|
|Income||5,886,757||5,886,757|
|Expenditure|(367,073)|(3,204,936)||(3,572,009)|
|Gain / (loss) on revaluation|||1,058,692|1,058,692|
|Transfers (see note 13521)|||||
|At 31March 2021|5,784,320|7,050,296|1,232,496|14,067,112|
||Designated
funds (see
note 21)f|Other
charitable
funds
f|Revaluation
reserve
f|Total|
|---|---|---|---|---|
|At 1 April 2019|6,487,621|4,110,056|519,839|11,117,516|
|Income||5,289,894||5,289,894|
|Expenditure|(493,681)|(4,912,797)||(5,406,478)|
|Gain / (loss) on revaluation|||(307,260)|(307,260)|
|Transfers (see note 13521)|229 675|190900|38 775||
|At 31March 2020|6,223,615|4,296,253|173,804|10,693,672|
##
##
##
##
##
##
##
##
##
##
|o which these amount|s
relate expire a|s follows:|||
|---|---|---|---|---|
||2021|2020|2021|2020|
||Land and
buildings
E|Land and
buildings
E|Other
E|Other
E|
|In one year or less|350,004|246,993|26,196|47,536|
|Between two and five|517,435|605,130|10,657|9,884|
|years|||||
|Over five years|151250|79479|||
||1,018,689|931,603|36,853|07,420|
##
##
##